Onyx doesn’t know why Nexavar increased the death rate in patients with squamous cell cancer, but it did say that it wasn’t the same bleeding problem that Avastin has. If it can get Nexavar approved for either of those indications, Onyx’s shares will soar again, but if they’re flubs like its lung cancer program, there’s little upside potential from here. Mother fights Army over son’s death.
It looks like the wonder drug isn’t so wonderful after all. Back to red After one quarter of profitability, expenses sent Onyx back into the red in the fourth quarter of last year. If Onyx and Bayer can get sales of Nexavar up to billion per year over the next few years and hypothetically decrease expenses to of sales which would kill their entire R amp. Subscribe to a blog search feed for Carboplatin dose in Google Reader. Jellies nightclub blackpool jellies reading jellies reading eyewear jellies recipe jellies recipes jellies sandal jellies sandals jellies shoes jellieszone jellieszone. Woes spur VA to widen probe.
(more̷